Literature DB >> 190363

Technetium-99m-pyrophosphate bone scans in hyperparathyroidism.

T Wiegmann, L Rosenthall, M Kaye.   

Abstract

Most patients with primary hyperparathyroidism have normal 5-hr bone-to-soft-tissue ratios for 99MTc-pyrophosphate. In contrast, all five patients with advanced secondary hyperparathyroidism in this study showed significant (p less than 0.001) increases of bone uptake. In the early period after parathyroidectomy, there was no quantitative or qualitative change in uptake. A limited decrease of bone uptake was observed only after prolonged periods of observation. In itself, parathyroid activity seems to have little direct influence on bone uptake of 99MTc-pyrophosphate.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 190363

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  14 in total

1.  Improvement of bone scintigraphy by quantitative evaluation compared with X-ray studies and iliac crest biopsy in malignant disease.

Authors:  J P Pfeifer; W Hill; U Büll; R Burkhardt; C M Kirsch
Journal:  Eur J Nucl Med       Date:  1983

2.  Observations on computerized quantitative bone scintigraphy in renal osteodystrophy.

Authors:  P de Graaf; E K Pauwels; P H Vos; I M Schicht; J te Velde; J de Graeff
Journal:  Eur J Nucl Med       Date:  1984

3.  Kinetics of 99mtechnetium-tin-methylene-diphosphonate in normal subjects and pathological conditions: a simple index of bone metabolism.

Authors:  A Caniggia; A Vattimo
Journal:  Calcif Tissue Int       Date:  1980       Impact factor: 4.333

4.  Increased bone radiotracer uptake in renal osteodystrophy. Clinical evidence of hyperparathyroidism as the major cause.

Authors:  P de Graaf; J te Velde; E K Pauwels; I M Schicht; K Kleiverda; J de Graeff
Journal:  Eur J Nucl Med       Date:  1982

5.  Tc-99m-HMDP bone uptake quantification and plasma osteocalcin levels in hemodialysis patients--a preliminary study.

Authors:  U Karayalcin; B Karayalcin; G Yakupoglu; A Yildiz; M Erkilic
Journal:  Ann Nucl Med       Date:  1992-02       Impact factor: 2.668

6.  The effect of parathyroid hormone on technetium-99m pyrophosphate distribution in rats.

Authors:  S E Halpern; P L Hagan; D M Chauncey; P Ayers
Journal:  Eur J Nucl Med       Date:  1980-12

7.  Diphosphonates in the evaluation of metabolic bone disease.

Authors:  I Fogelman; M L Smith
Journal:  Clin Rheumatol       Date:  1982-03       Impact factor: 2.980

8.  Evaluation of diffusely high uptake by the calvaria in bone scintigraphy.

Authors:  K Senda; S Itoh
Journal:  Ann Nucl Med       Date:  1987-09       Impact factor: 2.668

Review 9.  Skeletal scintigraphy.

Authors:  I R McDougall
Journal:  West J Med       Date:  1979-06

10.  A critical assessment of bone scan quantitation (bone to soft tissue ratios) in the diagnosis of metabolic bone disease.

Authors:  I Fogelman; R G Bessent; D Gordon
Journal:  Eur J Nucl Med       Date:  1981-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.